Compounded semaglutide
Sold by NativeMed · every compounded semaglutide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
Recorded initial charges
Initial payment · 3-month plan
$179
Monthly equivalent
$149
initial payment (3-month medication term), including required fees on record. The monthly equivalent is not a monthly bill. It combines the advertised medication rate with any recorded monthly membership and excludes one-time and annual fees. Renewal charges are not established by that figure. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.
| Medication · 3 Month Starter, sale price · recorded upfront charge for 3 months | $179 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| 3 Month Starter, sale price “3 Month STARTER monthly $328 less $149/mo | $449 $179 paid upfront per month first month $159” | Per month$149 | Charged today$179 |
Price sources
- 3 Month Starter, sale price · nativemed.net — read September 2026
We earn nothing from this link. It opens NativeMed's website without a paid referral.
History
Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.
- September 2026 — Entry added to the register
Sourcing and terms
| Prescriber | Asynchronous review |
|---|---|
| Cancellation | Absolutely! We understand that needs can change, so there are no long-term contracts or commitments beyond your chosen plan. Your satisfaction is our priority, and you’ll only be charged for medication that has already been shipped to you. |
Not yet checked: pharmacy, states, membership and consult fee.
Recorded from nativemed.net. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2026 — Product titles are "Semaglutide: Injection Home Kit" and "Tirzepatide: Injection Home Kit" and homepage describes both as "Weekly at home injection," but neither page states vial vs. pen, so form is recorded as not-disclosed rather than assumed. The semaglutide product page's pricing widget text is visually garbled by the site's variant-selector markup (duplicate "Regular price" labels); the $149/mo figure is the clearly marked sale price for the 3-month starter plan. No page states which US states are served.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.